Medeze Group Past Earnings Performance
Past criteria checks 6/6
Medeze Group has been growing earnings at an average annual rate of 32.7%, while the Healthcare industry saw earnings growing at 14% annually. Revenues have been growing at an average rate of 18.3% per year. Medeze Group's return on equity is 37.4%, and it has net margins of 34.7%.
Key information
32.7%
Earnings growth rate
19.5%
EPS growth rate
| Healthcare Industry Growth | 23.6% |
| Revenue growth rate | 18.3% |
| Return on equity | 37.4% |
| Net Margin | 34.7% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
No updates
Recent updates
No updates
Revenue & Expenses Breakdown
How Medeze Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 780 | 270 | 258 | 23 |
| 31 Mar 24 | 744 | 255 | 247 | 19 |
| 31 Dec 23 | 707 | 240 | 236 | 16 |
| 31 Dec 22 | 612 | 151 | 217 | 1 |
| 31 Dec 21 | 464 | 124 | 169 | 0 |
| 31 Dec 20 | 407 | 79 | 163 | 0 |
| 31 Dec 19 | 372 | 27 | 192 | 0 |
Quality Earnings: MEDEZE-R has high quality earnings.
Growing Profit Margin: MEDEZE-R's current net profit margins (34.7%) are higher than last year (29.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MEDEZE-R's earnings have grown significantly by 32.7% per year over the past 5 years.
Accelerating Growth: MEDEZE-R's earnings growth over the past year (38.8%) exceeds its 5-year average (32.7% per year).
Earnings vs Industry: MEDEZE-R earnings growth over the past year (38.8%) exceeded the Healthcare industry 16.7%.
Return on Equity
High ROE: MEDEZE-R's Return on Equity (37.4%) is considered high.